Last $1.16 USD
Change Today -0.03 / -2.52%
Volume 187.4K
RGDX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary D. Nusbaum

Former Independent Director, Chairman of Nominating & Governance Committee and Member of Audit Committee, Response Genetics, Inc
AgeTotal Calculated CompensationThis person is connected to 30 board members in 5 different organizations across 9 different industries.

See Board Relationships
47$32,500

Background*

Mr. Gary D. Nusbaum has been the Managing Director of E.M. Warburg Pincus & Co. LLC since January 1997. Mr. Nusbaum served as Managing Director of Palladium Equity Partners LLC, which he joined on June 14, 2006. He has more than 15 years of extensive experience in private equity, including the U.S. Hispanic market and Latin America and asset management. He also has responsibility for more than 20 investments including companies in the media, telecommunications, retail, ...

Read Full Background

Corporate Headquarters*

1640 Marengo Street
Los Angeles, California 90033

United States

Phone: 323-224-3900
Fax: 323-224-3096

Board Members Memberships*

Prior
Director
Director
Director
Director
Director
Director
Former Director
Director
Director
Member of the Board of Directors
1995-Present
Director
1999-2005
Former Director, Member of Compensation Committee and Member of Corporate Governance Committee
2007-2013
Former Independent Director, Chairman of Nominating & Governance Committee and Member of Audit Committee

Education*

BS 1988
The University of Pennsylvania
MBA 1989
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$32,500
Total Calculated Compensation$32,500
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RGDX:US $1.16 USD -0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc D. Grodman M.D.Founder, Chairman, Chief Executive Officer, President and Managing Director
Bio-Reference Laboratories Inc.
$1.2M
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$613.0K
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$500.0K
Michael J. Pellini M.D., MBAChief Executive Officer, President and Director
Foundation Medicine, Inc.
$403.9K
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESPONSE GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.